CIK 0000072444
- Accelerated filer
- Smaller reporting company
Vaxart, Inc.
Sign in to watch- Ticker
- VXRT
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 591212264
- Phone
- +1 650-550-3500
- Business address
- 310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
- Former names
- Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-16 | Tucker Sean Chief Scientific Officer | Option exercise | +1,006 | $6.49 | $7K | 48,053 |
| 2021-03-16 | Tucker Sean Chief Scientific Officer | Option exercise · Stock Option (right to buy) | −1,006 | 0 | ||
| 2021-03-04 | Latour Wouter Director | Option exercise | +150,000 | $0.77 | $116K | 150,000 |
| 2021-03-04 | Latour Wouter Director | Sale | −150,000 | $6.04 | $906K | 0 |
| 2021-03-04 | Latour Wouter Director | Option exercise · Stock Option (right to buy) | −150,000 | 213,261 | ||
| 2020-11-23 | Latour Wouter Director | Sale | −333,334 | $6.32 | $2.1M | 0 |
| 2020-08-25 | WILSON KAREN J Director | Grant or award · Stock Option (right to buy) | +65,700 | 65,700 | ||
| 2020-08-13 | Tucker Sean Chief Scientific Officer | Option exercise | +4,026 | $6.49 | $26K | 51,679 |
| 2020-08-13 | Tucker Sean Chief Scientific Officer | Option exercise · Stock Option (right to buy) | −4,026 | 0 | ||
| 2020-08-12 | Latour Wouter Director | Option exercise | +166,667 | $0.30 | $50K | 333,334 |
| 2020-08-12 | Latour Wouter Director | Option exercise · Common Stock Purchase Warrant | −166,667 | $0.30 | $50K | 0 |
| 2020-06-29 | ARMISTICE CAPITAL, LLC Director | Option exercise | +4,090,909 | $1.10 | $4.5M | 9,530,909 |
| 2020-06-29 | ARMISTICE CAPITAL, LLC Director | Option exercise | +0 | 9,530,909 | ||
| 2020-06-29 | ARMISTICE CAPITAL, LLC Director | Sale | −9,385,386 | $8.29 | $77.8M | 145,523 |
| 2020-06-29 | ARMISTICE CAPITAL, LLC Director | Sale | −0 | 145,523 | ||
| 2020-06-29 | ARMISTICE CAPITAL, LLC Director | Option exercise · Warrants | −4,090,909 | 0 | ||
| 2020-06-29 | ARMISTICE CAPITAL, LLC Director | Option exercise · Warrants | −0 | 0 | ||
| 2020-06-26 | ARMISTICE CAPITAL, LLC Director | Option exercise | +16,666,667 | $0.30 | $5.0M | 23,666,667 |
| 2020-06-26 | ARMISTICE CAPITAL, LLC Director | Option exercise | +0 | 23,666,667 | ||
| 2020-06-26 | ARMISTICE CAPITAL, LLC Director | Sale | −18,226,667 | $10.38 | $189.2M | 5,440,000 |
Page 14 of 23 · 442 trades